Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Agenus Inc (NQ: AGEN ) 17.73 +0.03 (+0.17%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 574,360 Open 17.20 Bid (Size) 17.31 (5) Ask (Size) 18.28 (8) Prev. Close 17.70 Today's Range 16.74 - 18.65 52wk Range 4.775 - 34.80 Shares Outstanding 348,875,959 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference June 28, 2024 From Agenus Inc. Via Business Wire Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies June 27, 2024 From Agenus Inc. Via Business Wire Performance YTD +10.78% +10.78% 1 Month +23.99% +23.99% 3 Month +228.33% +228.33% 6 Month +49.02% +49.02% 1 Year -48.16% -48.16% More News Read More Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors June 17, 2024 From Agenus Inc. Via Business Wire Up 40%: Is This Red-Hot Growth Stock Still a Buy? April 28, 2024 Via The Motley Fool Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50 June 13, 2024 From Agenus Via Business Wire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 04, 2024 Via Benzinga Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday June 04, 2024 Via Benzinga Agenus Announces Virtual Annual Shareholders Meeting June 04, 2024 From Agenus Inc. Via Business Wire Medical Moonshots: 3 Biotech Stocks Set to Skyrocket May 30, 2024 Via InvestorPlace 7 Biotech Stocks to Put on Your Breakthrough Radar May 27, 2024 Via InvestorPlace Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 24, 2024 From Agenus Inc. Via Business Wire Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting May 23, 2024 From Agenus Inc. Via Business Wire Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference May 23, 2024 From Agenus Inc. Via Business Wire 3 Magnificent Growth Stocks to Buy Hand Over Fist May 22, 2024 Via The Motley Fool Topics Economy Exposures Interest Rates FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer May 16, 2024 From Agenus Inc. Via Business Wire Agenus (AGEN) Q1 2024 Earnings Call Transcript May 07, 2024 Via The Motley Fool Topics Earnings Exposures Financial AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Agenus Reports First Quarter 2024 Results May 07, 2024 From Agenus Inc. Via Business Wire Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement May 07, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement May 01, 2024 From Agenus Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session April 26, 2024 Via Benzinga Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting April 24, 2024 From Agenus Inc. Via Business Wire Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month April 23, 2024 Via Benzinga Agenus to Provide First Quarter 2024 Financial Report and Corporate Update April 23, 2024 From Agenus Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
